Insulin News and Research

RSS

Insulin is a hormone that is needed to convert glucose, starches and other food into energy needed for daily life. Insulin allows cells to use glucose for fuel and is secreted by beta cells in the islets of Langerhans. The release of insulin from the pancreas is stimulated by increased blood glucose, vagal nerve stimulation, and other factors. Insulin is obtained from various animals and available in a variety of preparations. Commercial insulin preparations differ in a number of ways, including differences in the animal species from which they are obtained; their purity, concentration, and solubility; and the time of onset and duration of their biologic action. An oral hypoglycemic agent is not a form of insulin therapy.

Researchers assess effects of adding dapagliflozin to metformin or insulin in type 2 diabetes patients

Researchers used continuous glucose monitoring to assess the effects of adding dapagliflozin to a regimen of either metformin or insulin in patients with type 2 diabetes and found significant reductions in mean glucose and other glycemic factors, with greater improvements seen in patients taking metformin compared to insulin.

3 Oct 2018

Cancer undercuts ability of normal cells to consume glucose, finds study

Cancer needs energy to drive its out-of-control growth. It gets energy in the form of glucose, in fact consuming so much glucose that one method for imaging cancer simply looks for areas of extreme glucose consumption - where there is consumption, there is cancer.

29 Sep 2018

CIRM approves $1.6M grant to help bring human islet-like organoids to diabetic patients

Approximately 1.25 million Americans are living with type 1 diabetes, with an additional 40,000 people newly diagnosed every year.

27 Sep 2018

Study uncovers new molecule involved in regeneration of acute liver wounds

A new study from researchers of CEDOC-NOVA Medical School|Faculdade de Ciências Médicas and Instituto Gulbenkian de Ciência, led by Maria Paula Macedo and Carlos Penha-Gonçalves, respectively, published in Hepatology Communications, showed that a molecule CD26/DPP-4 is involved in the regeneration of acute liver wounds and is a promising biomarker for hepatic disease.

26 Sep 2018

TGen-UNM consortium awarded NIH grant to discover new treatments for diabetic blindness

Diabetes is an increasing global epidemic that is expected to grow by more than 50 percent in the next two decades, leaving more than half a billion patients worldwide exposed to potentially life-altering medical complications, including pain and numbness in the feet, lost limbs, life-threatening disorders of the heart, liver and kidneys -- and even blindness.

26 Sep 2018

BMI screening tool often fails to identify preschoolers with excess stomach fat

When assessing whether preschoolers are overweight, health professionals should use other measures such as waist-to-height ratio in addition to the Body Mass Index (BMI).

26 Sep 2018

One in five diabetes inpatients experienced hypoglycemia during hospital stay

Diabetes UK is urging healthcare professionals to be hypo-aware for Hypo-awareness Week (24th- 30th September). The charity wants to raise awareness about hypoglycemia and is encouraging healthcare professionals working in hospitals to look out for the signs of hypoglycemia and ensure those at high risk are given the necessary support.

25 Sep 2018

Study explores link between genetic predisposition to Alzheimer's and cardiometabolic risk factors

Alzheimer's disease is the most common memory disorder. In addition to genetic predisposition, the risk of Alzheimer's disease is also increased by cardiometabolic risk factors, such as type 2 diabetes. The accumulation of these risk factors is known as the metabolic syndrome.

25 Sep 2018

IQWiG recommends update in health care aspects of DMP ‘type 1 diabetes’

Disease management programmes should be regularly updated to adapt them to the current state of medical knowledge.

25 Sep 2018

Diets rich in carbohydrates reduce body weight and fat

Diets high in carbohydrates reduce body weight and body fat and improve insulin function in overweight individuals, according to a new study published in Nutrients.

25 Sep 2018

FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial

AstraZeneca today announced positive results from the Phase III DECLARE-TIMI 58 cardiovascular outcomes trial for FARXIGA, the broadest SGLT-2 inhibitor CVOT conducted to date.

24 Sep 2018

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

Takeda Pharmaceutical Company Limited today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion, recommending the full approval of ALUNBRIG® as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer previously treated with crizotinib.

24 Sep 2018

Insulin News and Research

Further Reading

Researchers assess effects of adding dapagliflozin to metformin or insulin in type 2 diabetes patients

Cancer undercuts ability of normal cells to consume glucose, finds study

CIRM approves $1.6M grant to help bring human islet-like organoids to diabetic patients

Study uncovers new molecule involved in regeneration of acute liver wounds

TGen-UNM consortium awarded NIH grant to discover new treatments for diabetic blindness

BMI screening tool often fails to identify preschoolers with excess stomach fat

One in five diabetes inpatients experienced hypoglycemia during hospital stay

Study explores link between genetic predisposition to Alzheimer's and cardiometabolic risk factors

IQWiG recommends update in health care aspects of DMP ‘type 1 diabetes’

Diets rich in carbohydrates reduce body weight and fat

FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

Insulin treatment shows great potential against chronic bowel inflammation

UNC scientists reveal new approach to prevent obesity and diabetes

From Syria to Southern California: Refugees seek care for wounds of war

Excess pregnancy weight gain affects cardiometabolic risk in offspring

UNIST to accelerate discovery, development of new medicines for incurable diseases

Study reveals prevalence of diagnosed type 1 and type 2 diabetes among American adults

FDA-approved 'safe' daily BPA exposure may contribute to insulin resistance

New research sheds light on the causes of diabetes

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News